Cullinan Therapeutics, Inc.

NasdaqGS:CGEM Stock Report

Market Cap: US$514.3m

Cullinan Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:CGEM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Feb 25SellUS$32,039Jacquelyn SumerIndividual3,756US$8.53
25 Feb 25SellUS$41,754Jeffrey JonesIndividual4,895US$8.53
25 Feb 25SellUS$32,039Jennifer MichaelsonIndividual3,756US$8.53
25 Feb 25SellUS$106,872Nadim AhmedIndividual12,529US$8.53
24 Dec 24SellUS$99,708Nadim AhmedIndividual8,400US$11.87
18 Dec 24SellUS$39,730Jacquelyn SumerIndividual3,482US$11.41
18 Dec 24SellUS$52,851Jeffrey JonesIndividual4,632US$11.41
18 Dec 24SellUS$53,547Jennifer MichaelsonIndividual4,693US$11.41
12 Dec 24SellUS$43,682Jennifer MichaelsonIndividual3,489US$12.52

Insider Trading Volume

Insider Buying: CGEM insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of CGEM?
Owner TypeNumber of SharesOwnership Percentage
Private Companies402,3060.589%
Individual Insiders2,351,3233.44%
VC/PE Firms7,648,26811.2%
Hedge Funds9,130,08213.4%
Institutions48,796,19771.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 35.9%.

Top Shareholders

Top 25 shareholders own 93.97% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.1%
MPM BioImpact LLC
7,648,268US$67.2m0%9.24%
9.83%
BVF Partners L.P.
5,750,683US$50.5m0%1.87%
7.47%
BlackRock, Inc.
4,371,025US$38.4m0.74%no data
5.78%
Deerfield Management Company, L.P. Series C
3,379,399US$29.7m3.03%0.59%
5.02%
The Vanguard Group, Inc.
2,936,227US$25.8m-2.08%no data
4.59%
Citadel Advisors LLC
2,682,904US$23.6m37.2%0.02%
4.05%
CHI Advisors LLC
2,370,972US$20.8m17.9%13.66%
3.73%
Franklin Resources, Inc.
2,180,497US$19.2m0.39%0.01%
3.63%
State Street Global Advisors, Inc.
2,124,484US$18.7m-9.1%no data
3.44%
AllianceBernstein L.P.
2,011,525US$17.7m8.47%0.01%
3.32%
OrbiMed Advisors LLC
1,942,555US$17.1m81.5%0.25%
3.03%
Morana Jovan-Embiricos
1,775,155US$15.6m0%no data
2.92%
RTW Investments, LP
1,705,960US$15.0m0%0.21%
2.36%
VR Adviser, LLC
1,379,965US$12.1m0%0.99%
2.25%
Dimensional Fund Advisors LP
1,318,372US$11.6m28.9%no data
2.21%
Foresite Capital Management, LLC
1,292,463US$11.4m96.5%2.66%
2.15%
Lynx1 Capital Management LP
1,257,795US$11.1m206%4.12%
2.14%
Kynam Capital Management, LP
1,252,738US$11.0m0%0.84%
2.08%
Geode Capital Management, LLC
1,214,641US$10.7m0.51%no data
2.07%
Invus Financial Advisors, LLC
1,211,357US$10.6m0%0.55%
2.01%
Braidwell LP
1,176,173US$10.3m0%0.5%
1.95%
Nextech Invest Ltd.
1,141,145US$10.0m0%1.95%
1.76%
Adage Capital Management, L.P.
1,030,438US$9.1m-24%0.02%
1.57%
Tang Capital Management, LLC
921,138US$8.1m0%0.46%
1.55%
Boxer Capital Management, LLC
907,895US$8.0m0%0.71%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/04 02:49
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cullinan Therapeutics, Inc. is covered by 13 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Thomas ShraderBTIG
Julian HarrisonBTIG
Kaveri PohlmanBTIG